Hit enter to search or ESC to close

Author: Alterity Therapeutics

Alterity Therapeutics Presents to Finance News Network

MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – June 4, 2019. Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is participating in the Finance News Network investor event today in Sydney. The event attracts a large number of retail, high net worth and sophisticated investors. The presentation follows the company’s strong presence at the ...

Alterity in the news: Herald Sun

Alterity Therapeutics was recently featured in The Herald Sun, helping to raise awareness about Multiple System Atrophy with Richmond Football Club and Ian “Doobs” Macindoe, the club’s former chief physiotherapist. To read the full story click on the link below.

Alterity Therapeutics commences US investor meetings following positive clinical data

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) is today commencing an investor roadshow in the US.  The meetings follow the Company’s presentation of clinical data from its Phase 1 clinical trial program for its investigative drug PBT434 at the American Academy of Neurology Annual Meeting last week. The data indicate that ...